MEDICLIN Aktiengesellschaft (FRA:MED)
2.900
-0.060 (-2.03%)
At close: Apr 17, 2025, 10:00 PM CET
FRA:MED Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 107.56 | 115.29 | 88.04 | 119.52 | 100.44 | Upgrade
|
Cash & Short-Term Investments | 107.56 | 115.29 | 88.04 | 119.52 | 100.44 | Upgrade
|
Cash Growth | -6.70% | 30.95% | -26.34% | 19.00% | 169.63% | Upgrade
|
Accounts Receivable | 99.57 | 81.58 | 88.49 | 81.21 | 76.34 | Upgrade
|
Other Receivables | 79.99 | 71.81 | 60.13 | 41.5 | 14.03 | Upgrade
|
Receivables | 179.56 | 153.39 | 148.62 | 122.72 | 90.37 | Upgrade
|
Inventory | 7.66 | 7.3 | 8.87 | 8.51 | 9.34 | Upgrade
|
Prepaid Expenses | - | - | - | 1.63 | 1.31 | Upgrade
|
Other Current Assets | 2.8 | 23.86 | 16.48 | 13.56 | 2.4 | Upgrade
|
Total Current Assets | 297.59 | 299.83 | 262.01 | 265.93 | 203.86 | Upgrade
|
Property, Plant & Equipment | 491.12 | 488.73 | 531.15 | 500.93 | 548.3 | Upgrade
|
Long-Term Investments | 0.06 | 0.07 | 0.07 | 0.07 | 0.09 | Upgrade
|
Goodwill | 16.4 | 16.69 | 49.87 | 49.87 | 49.25 | Upgrade
|
Other Intangible Assets | 6.55 | 5.23 | 4.17 | 5.82 | 7.9 | Upgrade
|
Long-Term Deferred Tax Assets | 11.14 | 11.03 | 10.49 | 10.66 | 11.02 | Upgrade
|
Other Long-Term Assets | 83.05 | 58.93 | 58.36 | 47.96 | 67.05 | Upgrade
|
Total Assets | 905.91 | 880.5 | 916.11 | 881.24 | 887.46 | Upgrade
|
Accounts Payable | 12.78 | 12.63 | 14.5 | 13.02 | 11.31 | Upgrade
|
Accrued Expenses | 26.61 | 26.59 | 24.17 | 26.63 | 24.66 | Upgrade
|
Short-Term Debt | - | - | - | - | 0.11 | Upgrade
|
Current Portion of Long-Term Debt | 1.86 | 1.96 | 26.77 | 26.84 | 26.78 | Upgrade
|
Current Portion of Leases | 26.59 | 24 | 23.41 | 54.94 | 54.01 | Upgrade
|
Current Income Taxes Payable | 8.02 | 3.54 | 4.7 | - | - | Upgrade
|
Current Unearned Revenue | - | - | - | 0.12 | 0.14 | Upgrade
|
Other Current Liabilities | 90.14 | 77.52 | 77.3 | 91.87 | 54.35 | Upgrade
|
Total Current Liabilities | 166.01 | 146.24 | 170.84 | 213.41 | 171.35 | Upgrade
|
Long-Term Debt | 65.1 | 91.42 | 67.54 | 69.34 | 71.2 | Upgrade
|
Long-Term Leases | 370.57 | 362.44 | 384.95 | 288.84 | 334.87 | Upgrade
|
Other Long-Term Liabilities | 43.29 | 42.64 | 43.23 | 65.27 | 64.79 | Upgrade
|
Total Liabilities | 683.17 | 684.47 | 706.79 | 698.22 | 710.62 | Upgrade
|
Common Stock | 47.5 | 47.5 | 47.5 | 47.5 | 47.5 | Upgrade
|
Additional Paid-In Capital | 129.34 | 129.34 | 129.34 | 129.34 | 129.34 | Upgrade
|
Retained Earnings | 45.61 | 19.03 | 32.31 | 6.39 | 0.27 | Upgrade
|
Comprehensive Income & Other | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | Upgrade
|
Total Common Equity | 222.51 | 195.92 | 209.21 | 183.28 | 177.16 | Upgrade
|
Minority Interest | 0.23 | 0.11 | 0.12 | -0.25 | -0.32 | Upgrade
|
Shareholders' Equity | 222.74 | 196.03 | 209.32 | 183.02 | 176.85 | Upgrade
|
Total Liabilities & Equity | 905.91 | 880.5 | 916.11 | 881.24 | 887.46 | Upgrade
|
Total Debt | 464.13 | 479.82 | 502.67 | 439.96 | 486.97 | Upgrade
|
Net Cash (Debt) | -356.56 | -364.54 | -414.63 | -320.44 | -386.53 | Upgrade
|
Net Cash Per Share | -7.51 | -7.67 | -8.73 | -6.75 | -8.14 | Upgrade
|
Filing Date Shares Outstanding | 47.5 | 47.5 | 47.5 | 47.5 | 47.5 | Upgrade
|
Total Common Shares Outstanding | 47.5 | 47.5 | 47.5 | 47.5 | 47.5 | Upgrade
|
Working Capital | 131.58 | 153.59 | 91.17 | 52.53 | 32.51 | Upgrade
|
Book Value Per Share | 4.68 | 4.12 | 4.40 | 3.86 | 3.73 | Upgrade
|
Tangible Book Value | 199.56 | 174.01 | 155.16 | 127.59 | 120.01 | Upgrade
|
Tangible Book Value Per Share | 4.20 | 3.66 | 3.27 | 2.69 | 2.53 | Upgrade
|
Land | 285.18 | 283.23 | 301.48 | 298.52 | 289.21 | Upgrade
|
Machinery | 227.92 | 218.05 | 220.07 | 215.67 | 223.92 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.